Global Point-of-Care Testing Market (POC) was valued US$ 14Bn in 2017 and is anticipated to reach US$ 30Bn by 2026 at a CAGR of about 10.0% during a forecast.
Global Point-of-Care (POC) Testing Market by product type, By Product Type, By End User and by region. Based on product type point of care market is segmented into Glucose Monitoring, Cardiac Markers, Infectious Diseases Testing, Cholesterol Testing, Coagulation Monitoring, Pregnancy And Fertility Testing, Haematology Testing, Blood Gas Testing & Others. By End-User are segmented in Clinics, Home, Laboratories, Assisted living healthcare facilities, Hospitals. Geographically into North America, Europe, Asia Pacific, Middle East & Africa, and Latin America.
The driving factor for the point of care market is due to Rising in usage of home-based glucose monitoring systems, Coagulation Monitoring, Infectious Diseases Testing, in trending Pregnancy And Fertility Testing, developing technology and innovative launching scheme and best offers to eventually reduce public and national spending on health, These devices are being highly used for the rapid diagnosis of disease conditions for the early detection and management of the disease are the factor of growth in point of care market. High logistics costs and huge investment will be the restrains for point of care market.
Global Point-of-Care (POC) Testing Market is segmented into by product, by Product Type, by End-user Type, and by geography. In terms Product Type, Infectious Diseases Testing will be in higher demand due to rising Point-of-care diagnostic are offering various schemes such as ease of use in remote areas, technological advancements, and lowered price points, tests are used in finger stick or capillary samples will be the key factor to boost the point of care market. In End, User segment Home Care will be fastest growing department due to Growing concern for early-stage disease detection and to avoid the occurrence of any chronic condition is expected to drive the remote monitoring and raise demand for rapid tests are a growth opportunity in the point-of-care testing market.
For More Information Visit https://www.maximizemarketresearch.com/market-report/global-point-of-care-testing-market/15349/
Among region, Asia Pacific is expected to grow at the highest CAGR during the forecast period. The market growth in the region can be attributed to the emerging economies, increasing in disposal income, Large-scale rising population, changing lifestyle and early safety and precaution will lead the step in these regions to boost the point-of-care testing market in the Asia Pacific.
Abbott Laboratories, Akers Biosciences, Inc., Alfa Scientific Designs, Inc, Amnisure International, Arlington Scientific, Inc, Becton Dickinson (BD), Biotron Diagnostics, Inc, Boson Biotech Co. Ltd, Chembio Diagnostic Systems, Inc, DRG International, Inc, Daktari Diagnostics, Diasys Diagnostic Systems Gmbh, Diazyme Laboratories, Inc., EKF Diagnostics Holdings plc, Eurolyser Diagnostica Gmbh, Getein Biomedical, Inc,. Hema Diagnostic Systems, LLC, Jant Pharmacal Corporation, Nova Biomedical, Corp., Princeton Biomeditech Corporation, Teco Diagnostics, Wama Diagnostica.
Scope of Global Point-of-Care (POC) Testing Market
Global Point-of-Care (POC) Testing Market by Product Type:
• Glucose Monitoring
• Cardiac Markers
• Infectious Diseases Testing
• Cholesterol Testing
• Coagulation Monitoring
• Pregnancy and Fertility Testing
• Hematology Testing
• Blood Gas Testing
• Others
Global Point-of-Care (POC) Testing Market by End-User Type
• Clinics
• Home Care
• Laboratories
• Assisted living healthcare facilities
• Hospitals
Global Point-of-Care (POC) Testing Market by Region
• North America
• Europe
• Asia Pacific
• Middle East & Africa
• Latin America
Key Player analyzed in the Report:
• Abbott
• Beckman Coulter Inc.
• Instrumentation Laboratory
• Johnson & Johnson
• Nova Biomedical
• Qiagen
• Roche Diagnostics Limited
• Siemens AG
• Abaxis, Inc.
• Abbott Laboratories
• Alfa Scientific Designs, Inc.
• ARKRAY, Inc.
• Ascencia Diabetes Care Holdings AG
• Becton Dickinson and Company
• bioMerieux SA
• CHEMBIO DIAGNOSTICS, INC.
• F. Hoffmann-La Roche AG
• LamdaGen Corporation
• Medtronic Public Limited Company
• Nova Biomedical
This Report Is Submitted By @Maximize Market Research Company
Customization of the report:
Maximize Market Research provides free personalized of reports as per your demand. This report can be personalized to meet your requirements. Get in touch with us and our sales team will guarantee provide you to get a report that suits your necessities.
About Maximize Market Research:
Maximize Market Research provides B2B and B2C research on 20,000 high growth emerging opportunities & technologies as well as threats to the companies across the Healthcare, Pharmaceuticals, Electronics & Communications, Internet of Things, Food and Beverages, Aerospace and Defense and other manufacturing sectors.
Contact info:
Name: Lumawant Godage
Organization: MAXIMIZE MARKET RESEARCH PVT. LTD.
Email: [email protected]
Address: Omkar Heights, Sinhagad Road, Manik Baug, Vadgaon Bk,Pune, Maharashtra 411051, India.
Contact: +91 20 6630 3320/ +919607065656/ +919607195908
A health care professional or a nurse performs the test, analysis is performed, and lastly the results are recorded.
Tests include lateral flow immunochromatography, enzyme-linked immunosorbent assays (ELISA), and agglutination test.Strong expertise with attention to detail makes our market research reports stand apart, Request a Report sample @ https://www.transparencymarketresearch.com/sample/sample.php?flag=S_id=25535 The health care industry has witnessed a major change in the past few years due to emerging technological innovations including biosensors, lab-on-a-chip, smartphone apps, and other wearable devices, contributing to a closer connection with the patient- point-of care technologies due to which it is becoming a part of the transformational healthcare landscape.
Increase in geriatric population, rise in prevalence of cardiovascular and diabetic diseases, and increased health care awareness are the major drivers of the market.
Improved technology, lab automation to provide cheaper, accurate, and high quality results, and increased home care facilities with rapid and effective diagnostic results also contribute to the growth of the point-of care lipid testing market.
Rural locations with limited lab services and shortage of trained laboratory workers present an opportunity for new entrants in developing countries.Pre Book Point of Care (POC) Lipid Testing Market Report –https://www.transparencymarketresearch.com/checkout.php?rep_id=25535=SBased on product type, the POC lipid testing market has been segmented into consumables and instruments.
In terms of application, the market has been segmented into hypertriglyceridemia, hyperlipoproteinemia, Tangier disease, hyperlipidemia, familial hypercholesterolemia, and others.
Point of Care (POC) diagnostics are tests that are designed to be used near the patient site which do not require a dedicated permanent area and are conducted outside clinical spaces.
The major drivers of this market include increased aging population, immediate test results and rising market penetration of EMR (Electronic Medical Records) and PACS (Picture Archiving and Communication Systems).
Additionally, shortage of skilled staff at the diagnostics facilities is expected to aid POC market penetration and positioning.
Out-care patient model which is an initiative taken by the governments to reduce stay in the hospitals along with homecare and other health care facilities are expected to help in promoting POC diagnostics.
POC diagnostics have initiated a decentralized trend in the healthcare industry which facilitates patients to be catered at remote locations, get early diagnostics and reduce costs.Adaptation of automated laboratory systems and highly integrated solutions facilitate the diagnostic workflow, which in turn drives adoption of point of care diagnostic/testing products.
Lack of skilled professionals or medical personnel with limited training especially in diagnostics can also easily use these devices.Rise in R activities among key players to introduce novel POC tests and devices for rapid disease detection and monitoring is expected to fuel industrial progression.
